We provide you with 20 years of free, institutional-grade data for PTGX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTGX. Explore the full financial landscape of PTGX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1377121 | PTGX | 10-Q | Url |
| 2025-05-06 | 1377121 | PTGX | 10-Q | Url |
| 2025-02-21 | 1377121 | PTGX | 10-K | Url |
| 2024-11-07 | 1377121 | PTGX | 10-Q | Url |
| 2024-08-06 | 1377121 | PTGX | 10-Q | Url |
| 2024-05-07 | 1377121 | PTGX | 10-Q | Url |
| 2024-02-27 | 1377121 | PTGX | 10-K | Url |
| 2023-11-02 | 1377121 | PTGX | 10-Q | Url |
| 2023-08-03 | 1377121 | PTGX | 10-Q | Url |
| 2023-05-04 | 1377121 | PTGX | 10-Q | Url |
| 2023-03-15 | 1377121 | PTGX | 10-K | Url |
| 2022-11-08 | 1377121 | PTGX | 10-Q | Url |
| 2022-08-04 | 1377121 | PTGX | 10-Q | Url |
| 2022-05-05 | 1377121 | PTGX | 10-Q | Url |
| 2022-02-28 | 1377121 | PTGX | 10-K | Url |
| 2021-11-03 | 1377121 | PTGX | 10-Q | Url |
| 2021-08-04 | 1377121 | PTGX | 10-Q | Url |
| 2021-05-04 | 1377121 | PTGX | 10-Q | Url |
| 2021-03-10 | 1377121 | PTGX | 10-K | Url |
| 2020-11-04 | 1377121 | PTGX | 10-Q | Url |
| 2020-08-06 | 1377121 | PTGX | 10-Q | Url |
| 2020-05-07 | 1377121 | PTGX | 10-Q | Url |
| 2020-03-10 | 1377121 | PTGX | 10-K | Url |
| 2019-11-06 | 1377121 | PTGX | 10-Q | Url |
| 2019-08-07 | 1377121 | PTGX | 10-Q | Url |
| 2019-05-08 | 1377121 | PTGX | 10-Q | Url |
| 2019-03-12 | 1377121 | PTGX | 10-K | Url |
| 2018-11-06 | 1377121 | PTGX | 10-Q | Url |
| 2018-08-07 | 1377121 | PTGX | 10-Q | Url |
| 2018-05-09 | 1377121 | PTGX | 10-Q | Url |
| 2018-03-07 | 1377121 | PTGX | 10-K | Url |
| 2017-11-07 | 1377121 | PTGX | 10-Q | Url |
| 2017-08-08 | 1377121 | PTGX | 10-Q | Url |
| 2017-05-10 | 1377121 | PTGX | 10-Q | Url |
| 2017-03-07 | 1377121 | PTGX | 10-K | Url |
| 2016-11-14 | 1377121 | PTGX | 10-Q | Url |
| 2016-09-15 | 1377121 | PTGX | 10-Q | Url |
| 2016-07-11 | 1377121 | PTGX | S-1 | Url |
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about PTGX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.